Nonthrombocytopenic Purpura Due to Miltown (2-Methyl-2-N-Propyl-1,3 Propanediol Dicarbamate)
- 18 October 1956
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 255 (16) , 770-771
- https://doi.org/10.1056/nejm195610182551608
Abstract
RECENTLY several new drugs have come into widespread use for their sedative or tranquilizing effects. The most widely publicized of these drugs is marketed under the trade names of Miltown and Equanil (2-methyl-2-n-propyl-1,3 propanediol dicarbamate).The pharmacology of this compound, which is related to mephenesin, has been studied by Berger1 and Hendley, Lynes and Berger.2 Its clinical use was reviewed by Selling3 and Borrus.4 The former reported 3 allergic reactions involving fever, urticaria and angioneurotic edema, among 187 patients; the latter observed no hematologic changes in 104 patients and did not mention allergic reactions.The object of this paper is . . .Keywords
This publication has 3 references indexed in Scilit:
- CLINICAL STUDY OF A NEW TRANQUILIZING DRUGJAMA, 1955
- STUDY OF EFFECT OF MILTOWN (2-METHYL-2-N-PROPYL-1,3-PROPANEDIOL DICARBAMATE) ON PSYCHIATRIC STATESJAMA, 1955
- Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on Central Nervous SystemExperimental Biology and Medicine, 1954